The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation
- PMID: 1425870
- DOI: 10.1007/BF01740660
The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation
Abstract
The present study was designed to investigate the effects of raised intragastric pH on the absorption of theophylline from a sustained-release formulation. Six healthy male volunteers participated in the cross-over randomised study and on one of two occasions were pretreated with 240 mg omeprazole, administered in three divided doses over the 22 h preceding the test. The sulphasalazine/sulphapyridine method of assessing oral-caecal transit time was implemented in order to assess upper bowel and colonic absorption. The mean fraction absorbed-time profile was calculated from serial serum theophylline concentration measurements by a modification of the Wagner-Nelson equation. During hypochlorhydria the mean oral-caecal transit time was 4.6 h, mean time to 90% absorption 6.8 h, and the percentage theophylline presumably to be absorbed from the colon 32.3. The corresponding values with normochlorhydria were, respectively, 3.8 h, 8.5 h, and 57.5%. The shorter oral-caecal transit time and lesser upper bowel absorption during normochlorhydria is postulated to result from motilin release due to duodenal acidification. Gastric hypoacidity resulted in significantly increased cumulative fractions of theophylline absorbed during a 3.5 h period, starting 0.5 h after breakfast. Possibly hypochlorhydria amplifies the increased motility which follows the intake of a meal, resulting in increased peristalsis and antiperistalsis, with more rapid drug absorption.
Similar articles
-
Fraction of theophylline in sustained-release formulation which is absorbed from the large bowel.Eur J Clin Pharmacol. 1990;38(2):171-3. doi: 10.1007/BF00265979. Eur J Clin Pharmacol. 1990. PMID: 1970960 Clinical Trial.
-
The influence of codeine, propantheline and metoclopramide on small bowel transit and theophylline absorption from a sustained-release formulation.Br J Clin Pharmacol. 1992 Mar;33(3):305-8. doi: 10.1111/j.1365-2125.1992.tb04040.x. Br J Clin Pharmacol. 1992. PMID: 1576052 Free PMC article. Clinical Trial.
-
The absorption characteristics of six sustained-release theophylline preparations.S Afr Med J. 1992 Jan 4;81(1):20-2. S Afr Med J. 1992. PMID: 1729729
-
Examining Small Intestinal Transit Time as a Function of Age: Is There Evidence to Support Age-Dependent Differences among Children?Drug Metab Dispos. 2016 Jul;44(7):1080-9. doi: 10.1124/dmd.115.068700. Epub 2016 Mar 14. Drug Metab Dispos. 2016. PMID: 26977099 Review.
-
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001. Clin Pharmacokinet. 1984. PMID: 6370542 Review.
Cited by
-
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.Clin Pharmacokinet. 1999 Mar;36(3):233-54. doi: 10.2165/00003088-199936030-00004. Clin Pharmacokinet. 1999. PMID: 10223170 Review.
-
Helicobacter pylori infection and hypochlorhydria in Zambian adults and children: A secondary data analysis.PLoS One. 2021 Aug 27;16(8):e0256487. doi: 10.1371/journal.pone.0256487. eCollection 2021. PLoS One. 2021. PMID: 34449790 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources